Altorki, Nasser Khaled
- Weill Cornell Medicine · Internal Medicine (NIH department code)
- Weill Cornell Medicine · Surgery (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #4,554
- Program Leader
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
- Surgery
NIH Funding · FY2023
Linked Award Amount
$1.8M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#4,554
By linked amount among FY2023 PIs
Earliest Year Loaded
2022
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Altorki, Nasser Khaled as a PI. Multi-PI records show the full award amount for context.
- 5U54CA272688-02U54Contact PICAP-IT Center for LNP RNA ImmunopreventionWeill Cornell Medicine · Internal Medicine (NIH department code)$1.1Maward amount
- 1R01CA271545-01A1R01Contact PIImmunoregulatory role of lung-resident club cell factors in lung cancerWeill Cornell Medicine · Surgery (NIH department code)$679.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing Altorki, Nasser Khaled as a PI.
FY2023 award administered by Weill Cornell Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2022First NIH AwardWeill Cornell Medicine
- 2022$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #7901
- 2022R01 Grant Holder
- 2023$2M Cumulative Funding
- 2023Entered Top 25% NationallyRanked #4554